Navigation Links
Forest Laboratories Announces Resignation of Ivan Gergel, MD
Date:3/19/2008

NEW YORK, March 19 /PRNewswire-FirstCall/ -- Forest Laboratories, Inc. (NYSE: FRX) today announced that Ivan Gergel, MD, Senior Vice President - Scientific Affairs and President of the Forest Research Institute has resigned his position and will leave the Company effective March 31, 2008.

(Logo: http://www.newscom.com/cgi-bin/prnh/20001011/FORESTLOGO )

Lawrence Olanoff, MD, PhD, President and Chief Operating Officer of Forest, stated: "The Board and I wish to thank Ivan Gergel for his ten years of service at Forest. His contributions are appreciated and have been especially significant for our CNS products, such as Celexa, Lexapro and Namenda. We wish him well in his future endeavors."

The Company is currently in the process of identifying a potential successor. In the interim the Forest Research Institute will continue to be overseen by Dr. Olanoff.

About Forest Laboratories Inc. and Its Products

Forest Laboratories (http://www.frx.com) is a U.S.-based pharmaceutical company dedicated to identifying, developing, and delivering products that make a positive difference in peoples' lives. Forest Laboratories' growing product line includes Lexapro(R) (escitalopram oxalate), an SSRI indicated for adults for the initial and maintenance treatment of major depressive disorder and generalized anxiety disorder; Namenda(R) (memantine HCl), an N-methyl D-aspartate (NMDA)-receptor antagonist indicated for the treatment of moderate to severe Alzheimer's disease; Campral(R)* (acamprosate calcium), indicated in combination with psychosocial support for the maintenance of abstinence from alco
'/>"/>

SOURCE Forest Laboratories, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Lake Forest Hospital Proposes a New Health Care System in Lake County
2. Forest Laboratories, Inc. and Merz Pharma GmbH & Co. KgaA File Lawsuits Against Several Companies for Patent Infringement
3. Forest Laboratories, Inc. Sets Date and Conference Call for Fiscal 2008 Third Quarter Earnings
4. Abbott Donates Cool Globe to Lake County Forest Preserves for Permanent Display at Greenbelt Cultural Center
5. Forest Laboratories and Cypress Bioscience to Host Webcast to Discuss Clinical Data Presentations for Milnacipran
6. Parasites a key to the decline of red colobus monkeys in forest fragments
7. Forest Laboratories, Inc. Sets Date and Conference Call for Fiscal 2008 Second Quarter Earnings
8. Out of the woods: Physicians get urban disaster training in forests, gorges and waters
9. Dr. Wei Sun, PhD, MD Joins SpectraCell Laboratories
10. Stiefel Laboratories, Inc. Appoints New President
11. Mylan Announces Appointment of Jagdish Dore as CEO and Managing Director of Matrix Laboratories

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/27/2009)... Nov. 27 Team Garmin-Slipstream, t...ted to ethical sporting and developing the next ge...t it will become Team Garmin-Transitions with the ...f the team. Transitions Optical is the world,s lea...e most advanced photochromic technology in the wid...
(Date:11/27/2009)...ngs has announced that it has become a national sp...est nonprofit organizations dedicated to arthritis... Delray Beach, FL (Vocus) November ... a company specializing in the marketing and retai...s announced today that is has become a national sp...
(Date:11/27/2009)...ical, economic burdens, study predicts , ...of people with diabetes in the United States is ex...dy predicts. , That would bring the total by 20...up from 23.7 million today. , , At the same time...riple, the study also warns, rising from an estima...
(Date:11/27/2009)...trade; announced today that Spectrum Health (Grand...rprise orthopedic templating solution and its Trau... (PRWEB) November 27, 2009 -- Voyant Healt...nd Rapids, Michigan) has licensed its TraumaCad En...aumaCad Extend workflow solution, to allow its ort...
(Date:11/27/2009)...ufacturers who use medical load cells at the heart...by bringing in technology partner Flintec early in...ive medical manufacturers are calling in Flintec l...jects, ensuring that progress will not be constrai...tdated technology. , (PRW...
Breaking Medicine News(10 mins):Health News:Team Garmin-Slipstream Officially Re-named Team Garmin-Transitions With Addition of Transitions Optical as New Sponsor 2Health News:Team Garmin-Slipstream Officially Re-named Team Garmin-Transitions With Addition of Transitions Optical as New Sponsor 3Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 2Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 3Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 4Health News:Diabetes Cases Expected to Double in 25 Years 2Health News:Diabetes Cases Expected to Double in 25 Years 3Health News:Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 2Health News:Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 3Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 2Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 3Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 4
...rmed at the evolution of causal organisms of hit...ey warn is the result of overzealous use of antibi...cement by the U.S Centers For Disease Control (CDC...creating worry lines on many a health expert. ...
...y predictor for liver cancer, says a US study. ...ne biomarker,// researchers at Columbia University... a means for early detection of liver cancer, says...have been associated with the development of liver...
...weight successfully should drink at least two litr...ction Centre in the German state of Rhineland-Pala...ht people drank too little and often mistook thirs...r metabolism and also improve skin tone. The...
...growing incidents of suicides and fratricides in t...ay called for steps to "urgently" address the// is...ases continues to be a cause of concern and must b...es in 2006. There have been 21 cases this year alo...
...ntries, those called up to risk their lives in the... and even ill-treated. Apparently the US is no exc...red out their grievances during a hearing of the P...th care system as a labyrinth, said their families...
...maceuticals Incorporated, a global biotechnology c...a trial on new hepatitis C drug, telaprevir. The d..., it has been shown. The planned interim resu...f the Liver (EASL). This drug has an enormous...
Other Medicine News:Health News:Blood DNA Predicts Liver Cancer Early 2Health News:Antony Concerned Over Growing Suicide Rates in Armed Forces 2Health News:Military Healthcare Lacks Compassion, Say US Soldiers 2Health News:New Hepatitis C Drug Shows Promise 2
(Date:11/25/2009)..., , MOUNTAIN VIEW, Calif., Nov. 25 /PRNewsw... Phase II/III clinical data from the Company,s PRO...aluation in Crohn,s disease Trial) of Traficet-EN(... Crohn,s disease demonstrated clinical efficacy wi...he study demonstrated evidence of clinical efficac...
(Date:11/24/2009)..., , PITTSBURGH, Nov. 24 ... have been in coma for 23 years following an auto ...uring that time and was the subject of a Good Morn...red in the segment to illustrate how people with L...communication. ,, WHEN: Good Morning America -...
(Date:11/24/2009)..., , MADISON, N.J., Nov. 24 /PRNewswire-...: DGX ), the world,s leading provider of diagnos...hat it is scheduled to speak at the 21st Annual Pi.... The presentation is scheduled for Wednesday, De...ring the conference, the company will reaffirm its...
Breaking Medicine Technology:ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 2ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 3ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 4ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 5ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 6DynaVox EyeMax Featured in Good Morning America Segment About Man Thought To Be in Coma for 23 Years 2Quest Diagnostics To Speak At The 21st Annual Piper Jaffray Healthcare Conference 2Bionovo Announces Pricing of Securities Offering 58766 1Bionovo Announces Pricing of Securities Offering 58766 2Bionovo Announces Pricing of Securities Offering 58766 3Yongye International Announces 2010 2012 Strategic Plan 14335 1Yongye International Announces 2010 2012 Strategic Plan 14335 2Yongye International Announces 2010 2012 Strategic Plan 14335 3Yongye International Announces 2010 2012 Strategic Plan 14335 4Yongye International Announces 2010 2012 Strategic Plan 14335 5Caraco Pharmaceutical Laboratories Ltd Closes Asset Purchase Agreement with Forest Laboratories Inc to Settle Lexapro 28R 29 28escitalopram oxala 5189 1Caraco Pharmaceutical Laboratories Ltd Closes Asset Purchase Agreement with Forest Laboratories Inc to Settle Lexapro 28R 29 28escitalopram oxala 5189 2
...T High-Risk Registry Data Shows Improved Symptomat...tients Treated with the MitraClip(R) System , , O...repair using the MitraClip(R) system in symptomati...al regurgitation (FMR) improves patient clinical s... 12-month data from the high-risk registry arm of ...
...RK, March 27 The Michael J. Fox Foundation announ... total to seven research teams working to improve ...nding was awarded under the Foundation,s Improvin...the Brain . The program is designed to address two...tive treatments for Parkinson,s disease: the need ...
Other Medicine Technology:MitraClip(R) Therapy Data Shows Important Clinical Benefit in High Risk Patients With Functional Mitral Regurgitation at 12-Month Follow Up 2MitraClip(R) Therapy Data Shows Important Clinical Benefit in High Risk Patients With Functional Mitral Regurgitation at 12-Month Follow Up 3Michael J. Fox Foundation Awards $2.1 Million to Improve Drug Delivery in Parkinson's Disease 2
...s a national reference laboratory and a worldwide ...opment. ARUP offers an extensive test menu of high...d anatomic pathology. Owned by the University of U...half of the nation's university teaching hospitals...
...s a national reference laboratory and a worldwide ...opment. ARUP offers an extensive test menu of high...d anatomic pathology. Owned by the University of U...half of the nation's university teaching hospitals...
...s a national reference laboratory and a worldwide ...opment. ARUP offers an extensive test menu of high...d anatomic pathology. Owned by the University of U...half of the nation's university teaching hospitals...
...s a national reference laboratory and a worldwide ...opment. ARUP offers an extensive test menu of high...d anatomic pathology. Owned by the University of U...half of the nation's university teaching hospitals...
Medicine Products: